| abstract |
An object of the present invention is to provide a heterocyclic compound having an IP6K inhibitory effect, and the compound is expected to be used as a preventive or therapeutic agent for diseases such as heart failure, diabetes and the like. The present invention relates to a compound represented by formula (I) or a salt thereof, wherein each symbol is as defined in the specification, which has an IP6K inhibitory effect and is expected to be used as a preventive or therapeutic agent for diseases such as heart failure, diabetes and the like . |